Patents by Inventor Stefan Lange

Stefan Lange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12269979
    Abstract: A lighting device includes a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(X D)n:E. MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn.
    Type: Grant
    Filed: November 6, 2023
    Date of Patent: April 8, 2025
    Assignee: OSRAM OLED GmbH
    Inventors: Markus Seibald, Simon Peschke, Gregor Hoerder, Gina Maya Achrainer, Klaus Wurst, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Bichler, Gudrun Plundrich
  • Patent number: 12258323
    Abstract: The present invention provides dihydrooxydiazinone compounds of general formula (I): in which R1, R2, R3, and R4, are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative diseases, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: March 25, 2025
    Assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Manuel Ellermann, Stefan Nikolaus Gradl, Charlotte Christine Kopitz, Martin Lange, Adrian Tersteegen, Philip Lienau, Christa Hegele-Hartung, Detlev Sülzle, Timothy A. Lewis, Heidi Greulich, Xiaoyun Wu, Matthew Meyerson, Alex Burgin
  • Patent number: 12255271
    Abstract: An optoelectronic unit includes a semiconductor chip configured to emit primary radiation with a first wavelength range during operation of the optoelectronic unit. The optoelectronic unit also includes a component including an optically active material. The component is arranged at least partially in the beam path of the semiconductor chip. The optically active material is not intended to be excited by the primary radiation with the first wavelength range. The optically active material incudes a proportion in the component of 0.004 wt %, inclusive, to 1 wt %, inclusive.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: March 18, 2025
    Assignee: ams-OSRAM International GmbH
    Inventors: Philipp Pust, Stefan Lange, Sebastian Stoll
  • Publication number: 20240200545
    Abstract: A method for monitoring an oil level of an oil-lubricated compressor, the method including: reading at least one oil level sensor, by which an oil level representing the compressor oil level is detected; checking compliance with at least one predetermined verification criterion for verification of the read-out oil level; and relaying an oil level signal if the read-out oil level complies with at least one relaying criterion according to whether the oil level reaches or falls below a predetermined oil level and with the at least one verification criterion.
    Type: Application
    Filed: September 2, 2021
    Publication date: June 20, 2024
    Inventors: Ehsan AFSHAR, Stefan LANGE Stefan LANGE, Adrian KRAMLICH, Rainer STROMAYR, Michael KRAMER
  • Patent number: 12013318
    Abstract: The present disclosure relates to a composition and its use for treating a sputum sample suspected to contain mycobacteria. The composition comprises thymol, a linear or branched alcohol, a chaotropic agent, a reducing agent, a detergent, and a buffer, and has a pH value between 8.5 and 10. Also disclosed is a method for treating a sputum sample suspected to contain mycobacteria.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: June 18, 2024
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Carolin Bier, Stefan Lange, Pirmin Hans Loetscher
  • Patent number: 11932791
    Abstract: A phosphor having the general formula EA7A2T1t1T2t2 T3t3NnOo:RE. EA is selected from the group of divalent elements. A is selected from the group of monovalent elements. T1 is selected from the group of trivalent elements. T2 is selected from the group of tetravalent elements. T3 is selected from the group of pentavalent elements. RE is an activator element. 16+3 t1+4 t2+5 t3?3n?2 o=0. t1+t2+t3=5; n+o=16; 0?t1?4; 0?t2?5; 0?t3?5; 0?n?9; 7?o?16.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 19, 2024
    Assignee: OSRAM Opto Semiconductors GmbH
    Inventors: Simon Peschke, Stefan Lange
  • Publication number: 20240067877
    Abstract: A lighting device includes a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(X D)n:E. MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn.
    Type: Application
    Filed: November 6, 2023
    Publication date: February 29, 2024
    Inventors: Markus SEIBALD, Simon PESCHKE, Gregor HOERDER, Gina Maya ACHRAINER, Klaus WURST, Dominik BAUMANN, Tim FIEDLER, Stefan LANGE, Hubert HUPPERTZ, Daniel DUTZLER, Thorsten SCHROEDER, Daniel BICHLER, Gudrun PLUNDRICH
  • Patent number: 11851596
    Abstract: A lighting device is specified. The lighting device comprises a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(XD)n:E. In this case, MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn. The following furthermore hold true: a+b+c+d=t; e+f+g+h+i+j=u; k+l+m+n=v; a+2b+3c+4d+e+2f+3g+4h+5i+6j?k?2l?3m?4n=w; 0.8?t?1; ?3.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: December 26, 2023
    Assignee: OSRAM OLED GmbH
    Inventors: Markus Seibald, Simon Peschke, Gregor Hoerder, Gina Maya Achrainer, Klaus Wurst, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Bichler, Gudrun Plundrich
  • Publication number: 20230290908
    Abstract: An optoelectronic unit includes a semiconductor chip configured to emit primary radiation with a first wavelength range during operation of the optoelectronic unit. The optoelectronic unit also includes a component including an optically active material. The component is arranged at least partially in the beam path of the semiconductor chip. The optically active material is not intended to be excited by the primary radiation with the first wavelength range. The optically active material incudes a proportion in the component of 0.004 wt%, inclusive, to 1 wt%, inclusive.
    Type: Application
    Filed: September 8, 2021
    Publication date: September 14, 2023
    Inventors: Philipp PUST, Stefan LANGE, Sebastian STOLL
  • Publication number: 20230235734
    Abstract: A compressor system including a compressor, a cooling device and a control apparatus, wherein the control apparatus is configured to control the cooling device independently of the operation of the compressor and to be capable of dynamically modifying a control parameter (Tair, Toil) of an actuator and/or the actuator for the actuation of the cooling device.
    Type: Application
    Filed: May 21, 2021
    Publication date: July 27, 2023
    Inventors: Adrian KRAMLICH, Stefan LANGE
  • Publication number: 20230142453
    Abstract: A radiation-emitting component may include a semiconductor chip and a conversion element. The semiconductor chip may be configured to emit electromagnetic radiation in a first wavelength range in the blue spectral region. The conversion element may have a first luminophore and a second luminophore. The first luminophore may be configured to emit electromagnetic radiation in the first wavelength range to electromagnetic radiation in a second wavelength range in the green spectral region. The second luminophore may be configured to convert at least electromagnetic radiation in the first wavelength range to electromagnetic radiation of a third wavelength range in the red spectral region.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 11, 2023
    Inventors: Dominik BAUMANN, Markus SEIBALD, Stefan LANGE, Frank JERMANN
  • Patent number: 11639465
    Abstract: A phosphor is specified. The phosphor has the general molecular formula: (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(XD)n:E. In this case, MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, -E=Eu, Ce, Yb and/or Mn, XC?N and XD=C. The following furthermore hold true: a+b+c+d=t; e+f+g+h+i+j=u; k+l+m+n=v; a+2b+3c+4d+e+2f+3g+4h+5i+6j?k?2l?3m?4n=w; 0.8?t?1; 3.5?u?4; 3.5?v?4; (?0.2)?w?0.2 and 0?m<0.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 2, 2023
    Assignee: OSRAM OLED GMBH
    Inventors: Markus Seibald, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Bichler, Gudrun Plundrich, Simon Peschke, Gregor Hoerder, Gina Maya Achrainer, Klaus Wurst
  • Publication number: 20230100663
    Abstract: A luminophore may have the general formula AzEeX6:RE, where A is selected from bivalent elements, E is selected from tetravalent elements, X is selected from monovalent elements, and RE is selected from activator elements. In addition, 0.9?z?1.1, and 0.9?e?1.1. A method for producing such a luminophore is also disclosed. A radiation-emitting component may further include the luminophore.
    Type: Application
    Filed: March 15, 2021
    Publication date: March 30, 2023
    Inventors: Dominik BAUMANN, Markus SEIBALD, Stefan LANGE, Jascha BANDEMEHR, Florian KRAUS
  • Patent number: 11566174
    Abstract: A phosphor is specified. The phosphor has the general molecular formula: (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(XD)n:E. In this case, MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, -E=Eu, Ce, Yb and/or Mn, XC=N and XD=C. The following furthermore hold true: a+b+c+d=t; e+f+g+h+i+j=u; k+l+m+n=v; a+2b+3c+4d+e+2f+3g+4h+5i+6j?k?2l?3m?4n=w; 0.8?t?1; 3.5?u?4; 3.5?v?4; (?0.2)?w?0.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: January 31, 2023
    Assignee: OSRAM OLED GMBH
    Inventors: Markus Seibald, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Biehler, Simon Peschke
  • Publication number: 20220315836
    Abstract: A lighting device is specified. The lighting device comprises a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(XD)n:E. In this case, MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn. The following furthermore hold true: a+b+c+d=t; e+f+g+h+i+j=u; k+l+m+n=v; a+2b+3c+4d+e+2f+3g+4h+5i+6j?k?2l?3m?4n=w; 0.8?t?1; ?3.
    Type: Application
    Filed: June 10, 2022
    Publication date: October 6, 2022
    Inventors: Markus Seibald, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Bichler, Gudrun Plundrich, Simon Peschke, Gregor Hoerder, Gina Maya Achrainer, Klaus Wurst
  • Patent number: 11453822
    Abstract: A lighting device is specified. The lighting device comprises a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(XD)n:E. In this case, MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn. The following furthermore hold true: a+b+c+d=t; e+f+g+h+i+j=u; k+l+m+n=v; a+2b+3c+4d+e+2f+3g+4h+5i+6j?k?2l?3m?4n=w; 0.8?t?1; ?3.
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: September 27, 2022
    Assignee: OSRAM OLED GMBH
    Inventors: Markus Seibald, Dominik Baumann, Tim Fiedler, Stefan Lange, Hubert Huppertz, Daniel Dutzler, Thorsten Schroeder, Daniel Bichler, Gudrun Plundrich, Simon Peschke, Gregor Hoerder, Gina Maya Achrainer, Klaus Wurst
  • Publication number: 20220259635
    Abstract: The present disclosure relates to a composition and its use for treating a sputum sample suspected to contain mycobacteria. The composition comprises thymol, a linear or branched alcohol, a chaotropic agent, a reducing agent, a detergent, and a buffer, and has a pH value between 8.5 and 10. Also disclosed is a method for treating a sputum sample suspected to contain mycobacteria.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Inventors: Carolin Bier, Stefan Lange, Pirmin Hans Loetscher
  • Patent number: 11407796
    Abstract: The present invention relates to a new peptide called Antisecretory Factor (AF) 17 which is an isolated recombinant and/or synthetically produced which has a t½ of at least 1.8 h. The peptide is e.g. useful for normalizing pathological fluid transport and/or inflammatory reactions in animals and in humans. AF-17 and pharmaceutical compositions of AF-17 can e.g. be used for treating and/or preventing TBI and/or secondary brain injuries associated with TBI, as well as for treating and/or preventing acquired brain injuries and to optimize cancer treatment.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: August 9, 2022
    Assignee: LANTMÄNNEN AS-FAKTOR AB
    Inventor: Stefan Lange
  • Patent number: 11352654
    Abstract: The present disclosure relates to a composition and its use for treating a sputum sample suspected to contain mycobacteria. The composition comprises thymol, a linear or branched alcohol, a chaotropic agent, a reducing agent, a detergent, and a buffer, and has a pH value between 8.5 and 10. Also disclosed is a method for treating a sputum sample suspected to contain mycobacteria.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: June 7, 2022
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Carolin Bier, Stefan Lange, Pirmin Hans Loetscher
  • Publication number: 20220135880
    Abstract: A phosphor having the general formula EA7A2T1t1T2t2 T3t3NnOo:RE. EA is selected from the group of divalent elements. A is selected from the group of monovalent elements. T1 is selected from the group of trivalent elements. T2 is selected from the group of tetravalent elements. T3 is selected from the group of pentavalent elements. RE is an activator element. 16+3 t1+4 t2+5 t3?3n?2 o=0. t1+t2+t3=5; n+o=16; 0?t1?4; 0?t2?5; 0?t3?5; 0?n?9; 7?o?16.
    Type: Application
    Filed: February 14, 2020
    Publication date: May 5, 2022
    Inventors: Simon Peschke, Stefan Lange